Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK7 | Q13164 | 9/20 | 0.55 |
| ▸ | BRD4 | O60885 | 9/20 | 0.55 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | DCLK1 | O15075 | 2/20 | 0.42 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.42 |
| ▸ | BRDT | Q58F21 | 2/20 | 0.42 |
| ▸ | PLK4 | O00444 | 1/20 | 0.42 |
| ▸ | PI4KA | P42356 | 1/20 | 0.42 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.42 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.42 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.42 |
| ▸ | TNK1 | Q13470 | 1/20 | 0.42 |
| ▸ | RPS6KA2 | Q15349 | 1/20 | 0.42 |
| ▸ | RPS6KA1 | Q15418 | 1/20 | 0.42 |
| ▸ | DCLK2 | Q8N568 | 1/20 | 0.42 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.42 |
| ▸ | AURKA | O14965 | 1/20 | 0.42 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.42 |
| ▸ | CDK2 | P24941 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18369841 | 0.82 | MAPK7 (0.61) | MAPK7BRD4MAPK10KCNH2DCLK1 | |
| SCHEMBL17059748 | 0.82 | MAPK7 (0.61) | MAPK7BRD4KCNH2DCLK1LRRK2 | |
| SCHEMBL17059943 | 0.80 | BRD4 (0.62) | MAPK7BRD4KCNH2DCLK1LRRK2 | |
| SCHEMBL18370001 | 0.78 | MAPK7 (0.69) | MAPK7BRD4KCNH2DCLK1LRRK2 | |
| SCHEMBL18369927 | 0.73 | MAPK7 (0.62) | MAPK7BRD4KCNH2DCLK1LRRK2 | |
| SCHEMBL17059742 | 0.73 | MAPK7 (0.57) | MAPK7BRD4DCLK1LRRK2BRDT | |
| SCHEMBL18369936 | 0.73 | MAPK7 (0.61) | MAPK7BRD4KCNH2DCLK1LRRK2 | |
| SCHEMBL18369845 | 0.72 | MAPK7 (0.54) | MAPK7BRD4MAPK10KCNH2DCLK1 | |
| SCHEMBL18369942 | 0.71 | MAPK7 (0.62) | MAPK7BRD4KCNH2DCLK1LRRK2 | |
| SCHEMBL17059946 | 0.71 | MAPK7 (1.00) | MAPK7BRD4DCLK1LRRK2BRDT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170008888-A1 | HETEROCYCLIC COMPOUNDS | ACTIVX BIOSCIENCES, INC. | 2017-01-12 | — | — | US | disclosed |
| US-20170008888-A1 | HETEROCYCLIC COMPOUNDS | ACTIVX BIOSCIENCES, INC. | 2017-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170008888-A1 | HETEROCYCLIC COMPOUNDS | BET1, EP300, RBBP5 | MAPK7 58/4885BRD4 4/4885MAPK10 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.